Empowered Funds
OKUR icon

Empowered Funds’s OnKure Therapeutics OKUR Stock Holding History

Empowered Funds’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$145K Buy
+53,097
New +$200K ﹤0.01% 2355

Other funds holding OKUR

Vivo Capital
Vivo Capital Palo Alto, California $909M AUM 385.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Prosight Management
Prosight Management Dallas, Texas $515M AUM 2.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.6B AUM 33.98% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Carlyle Group
Carlyle Group Washington, District of Columbia $8.36B AUM 14.46% 1-Year Est. Return

Empowered Funds's OKUR Position: Q3 2026 in Review

Empowered Funds opened a new position in OnKure Therapeutics (OKUR) in Q3 2026: 53,097 shares worth $145K. The stake represents ﹤0.01% of the portfolio and ranks #2355 among its holdings.

45 funds tracked by Wall St. Rank hold OKUR as of Q3 2026.

  • Empowered Funds held 53,097 shares of OnKure Therapeutics worth $145K as of Q3 2026.
  • OnKure Therapeutics was a new Empowered Funds position in Q3 2026.
  • OnKure Therapeutics made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2355 holding.
  • 45 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.